$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation

Journal of hepatology : the journal of the European Association for the Study of the Liver, v.28 no.3, 1998년, pp.359 - 368  

Lau, G.K.K. (Department of Medicine Queen Mary Hospital,, , Hong Kong) ,  Liang, R. ,  Wu, P.C. ,  Lee, C.K. ,  Lim, W.L. ,  Au, W.Y.

Abstract AI-Helper 아이콘AI-Helper

Background/Aims: Reactivation of chronic hepatitis B viral infection causes significant morbidity and mortality after bone marrow transplantation. Recently, nucleoside analogues, such as famciclovir, were found to have a direct suppressive effect on hepatitis B virus replication in both in vitro and...

참고문헌 (39)

  1. Ann Intern Med Hoffnagle 96 447 1982 10.7326/0003-4819-96-4-447 Reactivation of chronic hepatitis B virus infection by cancer chemotherapy 

  2. Lancet Galbraith ii 528 1975 10.1016/S0140-6736(75)90897-1 Fulminant hepatic failure in leukemia and choriocacinoma related to withdrawal of cytotoxic drug therapy 

  3. Q J Med Bird 73 895 1989 Acute liver decomposition on withdrawal of cytotoxic therapy and immunosuppressive therapy in hepatitis B carriers 

  4. Q J Med Lau 36 47 1989 Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients 

  5. Gastroenterology Scullard 81 978 1981 10.1016/S0016-5085(81)80002-9 Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B 

  6. Gastroenterology Davis 92 2028 1987 10.1016/0016-5085(87)90641-X Reactivation of chronic hepatitis B virus infection 

  7. Hematol Oncol Liang 8 261 1990 10.1002/hon.2900080504 Hepatitis B infection in patients with lymphomas 

  8. Gastroenterology Lok 100 182 1991 10.1016/0016-5085(91)90599-G Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy 

  9. Bone Marrow Transplant Lau 19 795 1997 10.1038/sj.bmt.1700744 Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case-controlled study 

  10. Dig Dis Sci Pariente 33 1185 1988 10.1007/BF01535798 Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation 

  11. N Engl J Med Dientstag 333 1657 1995 10.1056/NEJM199512213332501 A preliminary trial of lamuvidine for chronic hepatitis B infection 

  12. J Viral Hepatitis Main 3 211 1996 10.1111/j.1365-2893.1996.tb00098.x A double blind, placebo-controlled study to assess the effect of famciclovir on viral replication in patients with chronic hepatitis B virus infection 

  13. J Hepatol Schalm 22 52 1995 New nucleosides analogues for chronic hepatitis B 

  14. Hepatology Kruger 22 219A 1995 10.1016/0270-9139(95)94599-7 Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation 

  15. Hepatology Rabinovitz 24 282A 1996 Famciclovir for recurrent hepatitis B (HBV) infection after liver transplantation 

  16. Antimicrob Agents Chemother Shaw 38 719 1994 10.1128/AAC.38.4.719 In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus 

  17. Transplantation Jones 44 778 1987 10.1097/00007890-198712000-00011 Venoocclusive disease of the liver following bone marrow transplantation 

  18. Transplantation Glucksberg 18 295 1974 10.1097/00007890-197410000-00001 Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors 

  19. J Clin Oncol Beyer 13 1328 1995 10.1200/JCO.1995.13.6.1328 Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison 

  20. Hepatology Lau 25 1497 1997 10.1002/hep.510250631 Clearance of HBsAg after bone marrow transplantation: role of adoptive immunity transfer 

  21. Nucleic Acids Res Symp Ser Urdea 24 197 1991 Branched DNA amplification multimer for the sensitive, direct detection of human hepatitis viruses 

  22. J Hepatol Chung 17 208 1993 10.1016/S0168-8278(05)80040-6 Re-evaluation of α-interferon treatment of chronic hepatitis B using polymerase chain reaction 

  23. Hepatology Lau 23 1318 1996 Hepatic expression of hepatitis C virus in chronic hepatitis C: a study by in-situ reverse transcription polymerase chain reaction 

  24. Lancet Jarvis 348 1352 1996 10.1016/S0140-6736(96)04041-X Infection with hepatitis G virus among recipients of plasma products 

  25. Hepatology Knodell 1 431 1981 10.1002/hep.1840010511 Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis 

  26. Am J Clin Pathol Wu 105 87 1996 10.1093/ajcp/105.1.87 Hepatic expression of hepatitis B virus genome in chronic hepatitis B virus infection 

  27. Proc Natl Acad Sci USA Nowak 93 4398 1996 10.1073/pnas.93.9.4398 Viral dynamics in hepatitis B virus infection 

  28. J Hepatol Roche 26 517 1997 10.1016/S0168-8278(97)80416-3 De novo and apparent de novo hepatitis B virus infection after liver transplantation 

  29. Proc Natl Acad Sci USA Tur Kaspa 83 1627 1986 10.1073/pnas.83.6.1627 Hepatitis B virus DNA contains a glucocorticoid-responsive element 

  30. J Hepatol Aye 26 1148 1997 10.1016/S0168-8278(97)80125-0 Hepatitis B virus polymerase mutation during famciclovir therapy in patients with following liver transplantation 

  31. Hepatology Trepo 24 188A 1996 Efficacy of famciclovir in chronic hepatitis B: results of a dose finding study 

  32. J Hepatol Trepo 26 74 1997 Long-term efficacy of famciclovir (FVC) in chronic hepatitis B: results of a phase IIB study 

  33. Ann Intern Med Lok 116 957 1992 10.7326/0003-4819-116-11-957_2 Recovery from hepatitis B [letter] 

  34. Gastroenterology Ilan 104 1818 1993 10.1016/0016-5085(93)90664-X Ablation of persistent hepatitis B by BMT from a hepatitis B immune donor 

  35. Blood Lum 69 369 1987 10.1182/blood.V69.2.369.369 The kinetics of immune reconstitution after human marrow transplantation 

  36. Gastroenterology Hoofnagle 95 1318 1988 10.1016/0016-5085(88)90367-8 Randomised, controlled trial of recombinant human-interferon in patients with chronic hepatitis B 

  37. Lancet Lok ii 298 1988 10.1016/S0140-6736(88)92355-0 Long-term follow-up in a randomised controlled trial of recombinant-interferon in Chinese patients with chronic hepatitis B virus infection 

  38. Lancet Alexander ii 66 1987 10.1016/S0140-6736(87)92735-8 Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection 

  39. J Clin Oncol Ayash 8 1699 1990 10.1200/JCO.1990.8.10.1699 Hepatic veno-occlusive disease in autologous bone marrow transplantation of solid tumors and lymphoma 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로